Financing Benefits and Barriers to Routine HIV Screening in Clinical Settings in the United States: A Scoping Review
Abstract
:1. Introduction
2. Materials and Methods
2.1. Sources and Eligibility Criteria
2.2. Search Strategy
- HIV: HIV or human immunodeficiency virus, AND;
- Screening: (screen OR screening) OR (test OR testing OR HIV test), AND;
- United States: (including all states and excluding all other countries);
- Financial benefits and financial barriers: (cost benefit* or cost effective* or cost utility or (economic adj2 evaluat*) or marginal analys* or financial benefit* or financial barrier* or (3acilit* adj2 (barrier* or benefit* or 3acility3*))) AND;
- Clinical settings: (emergency room* or emergency department* or emergency service*) OR (inpatient* or outpatient* or hospital* or ambulatory care or ambulatory clinic* or community health center* or healthcare faciltit* or health care acility*or or health 4acility*).
2.3. Selection and Data Charting
2.4. Data Items
- Financial benefits of, and barriers to, HIV screening in healthcare settings;
- Cost-effectiveness of routine HIV screening in clinical settings. Some refer to this as mass/general. We will use the term routine for the remainder of the paper.
3. Results
3.1. Financial Benefits of and Barriers to HIV Screening in Healthcare Settings
3.2. Cost-Effectiveness of Routine HIV Screening in Clinical Settings
4. Discussion and Recommendations
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Centers for Disease Control and Prevention (CDC). Estimated HIV incidence and prevalence in the United States, 2015–2019. In HIV Surveillance Supplemental Report 2021; No. 1; CDC: Atlanta, GA, USA, 2021; Volume 26. [Google Scholar]
- Department of Health and Human Services. HIV National Strategic Plan: A Roadmap to End the Epidemic for the United States (2021–2025). 2020. Available online: https://files.hiv.gov/s3fs-public/HIV-National-Strategic-Plan-2021-2025.pdf (accessed on 15 October 2022).
- White, B.L.; Walsh, J.; Rayasam, S.; Pathman, D.E.; Adimora, A.A.; Golin, C.E. What makes me screen for HIV? Perceived barriers and facilitators to conducting recommended routine HIV testing among primary care physicians in the Southeastern United States. J. Int. Assoc. Provid. AIDS Care JIAPAC 2015, 14, 127–135. [Google Scholar] [CrossRef] [PubMed]
- Cohen, M.S.; Chen, C.Y.; McCauley, M.; Gamble, T.; Hosseinipour, M.C.; Kumarasamy, N.; Hakim, J.G.; Kumwenda, J.; Grinsztejn, B.; Pilotto, J.H.; et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N. Engl. J. Med. 2016, 2016, 830–839. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention (CDC). HIV Testing. 2018. Available online: https://www.cdc.gov/hiv/testing/index.html (accessed on 7 November 2018).
- Young, S.D.; Monin, B.; Owens, D. Opt-out testing for stigmatized diseases: A social psychological approach to understanding the potential effect of recommendations for routine HIV testing. Health Psychol. 2009, 28, 675–681. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Obermeyer, C.M.; Osborn, M. The utilization of testing and counseling for HIV: A review of the social and behavioral evidence. Am. J. Public Health 2007, 97, 1762–1774. [Google Scholar] [CrossRef] [PubMed]
- US Preventive Services Task Force; Owens, D.K.; Davidson, K.W.; Krist, A.H.; Barry, M.J.; Cabana, M.; Caughey, A.B.; Curry, S.J.; Doubeni, C.A.; Epling, J.W., Jr.; et al. Screening for HIV Infection: U.S. Preventive Services Task Force Recommendation Statement. JAMA 2019, 321, 2326–2336. [Google Scholar] [CrossRef] [Green Version]
- Gebrezgi, M.T.; Mauck, D.E.; Sheehan, D.M.; Fennie, K.P.; Cyrus, E.; Degarege, A.; Trepka, M.J. Acceptance of Opt-Out HIV Screening in Outpatient Settings in the United States: A Systematic Review and Meta-Analysis. Public Health Rep. 2019, 134, 484–492. [Google Scholar] [CrossRef]
- Arksey, H.; O’Malley, L. Scoping Studies: Towards a Methodological Framework. Int. J. Social Res. Methodol. 2005, 8, 19–32. [Google Scholar] [CrossRef] [Green Version]
- Li, X.C.; Kusi, L.; Marak, T.; Bertrand, T.; Chan, P.A.; Galarraga, O. The Cost and Cost-utility of Three Public Health HIV Case-finding Strategies: Evidence from Rhode Island, 2012–2014. AIDS Behav. 2018, 22, 3726–3733. [Google Scholar] [CrossRef]
- Gidwani, R.; Goetz, M.B.; Kominski, G.; Asch, S.; Mattocks, K.; Samet, J.H.; Justice, A.; Gandhi, N.; Needleman, J. A budget impact analysis of rapid human immunodeficiency virus screening in veterans administration emergency departments. J. Emerg. Med. 2012, 42, 719–726. [Google Scholar] [CrossRef] [Green Version]
- Eggman, A.A.; Feaster, D.J.; Leff, J.A.; Golden, M.R.; Castellon, P.C.; Gooden, L.; Matheson, T.; Colfax, G.N.; Metsch, L.R.; Schalckman, B.R. The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United States. Sex. Transm. Dis. 2014, 41, 545–550. [Google Scholar] [CrossRef]
- Spaulding, A.C.; MacGowan, R.J.; Copeland, B.; Shrestha, R.K.; Bowden, C.J.; Kim, M.J.; Margolis, A.D.; Mustaafaa, G.; Reid, L.C.; Heilpern, K.L.; et al. Costs of rapid HIV screening in an urban emergency department and a nearby county jail in the Southeastern United States. PLoS ONE 2015, 10, e0128408. [Google Scholar] [CrossRef] [Green Version]
- Schackman, B.R.; Eggman, A.A.; Leff, J.A.; Braunlin, M.; Felsen, U.R.; Fitzpatrick, L.; Telzak, E.E.; El-Sadr, W.; Branson, B.M. Costs of expanded rapid HIV testing in four emergency departments. Public Health Rep. 2016, 131 (Suppl. S1), 71–81. [Google Scholar] [CrossRef] [Green Version]
- Anaya, H.D.; Chan, K.; Karmarkar, U.; Asch, S.M.; Bidwell Goetz, M. Budget impact analysis of HIV testing in the VA Healthcare System. Value Health 2012, 15, 1022–1028. [Google Scholar] [CrossRef] [Green Version]
- Sison, N.; Yolken, A.; Poceta, J.; Mena, L.; Chan, P.A.; Barnes, A.; Smith, E.; Nunn, A. Healthcare provider attitudes, practices, and recommendations for enhancing routine HIV testing and linkage to care in the Mississippi Delta region. AIDS Patient Care STDs 2013, 27, 511–517. [Google Scholar] [CrossRef] [Green Version]
- Bartlett, J.G.; Branson, B.M.; Fenton, K.; Hauschild, B.C.; Miller, V.; Mayer, K.H. Opt-out testing for human immunodeficiency virus in the United States: Progress and challenges. JAMA 2008, 300, 945–951. [Google Scholar] [CrossRef]
- Mehta, A.S.; Goyal, M.K.; Dowshen, N.; Mistry, R.D. Practices, Beliefs, and Perceived Barriers to Adolescent Human Immunodeficiency Virus Screening in the Emergency Department. Pediatr. Emerg. Care 2015, 31, 621–626. [Google Scholar] [CrossRef]
- NEJM Catalyst. What Are Bundled Payments? 2018. Available online: https://catalyst.nejm.org/doi/full/10.1056/CAT.18.0247 (accessed on 19 January 2020).
- Farnham, P.G.; Sansom, S.L.; Hutchinson, A.B. How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in U.S. clinical settings. Med. Decis. Mak. Int. J. Soc. Med. Decis. Mak. 2012, 32, 459–469. [Google Scholar] [CrossRef]
- Sanders, G.D.; Anaya, H.D.; Asch, S.; Hoang, T.; Golden, J.F.; Bayoumi, A.M.; Owens, D.K. Cost-effectiveness of strategies to improve HIV testing and receipt of results: Economic analysis of a randomized controlled trial. J. Gen. Intern. Med. 2010, 25, 556–563. [Google Scholar] [CrossRef] [Green Version]
- Owens, D.K.; Sundaram, V.; Lazzeroni, L.C.; Douglass, L.R.; Sanders, G.D.; Taylor, K.; Van Groningen, R.; Shadle, V.M.; McWhorter, V.C.; Agoncillo, T.; et al. Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: Implications for screening programs for HIV. Am. J. Public Health 2007, 97, 2173–2178. [Google Scholar] [CrossRef]
- Torres, G.W.; Heffelfinger, J.D.; Pollack, H.A.; Barrera, S.G.; Rothman, R.E. HIV screening programs in U.S. emergency departments: A cross-site comparison of structure, process, and outcomes. Ann. Emerg. Med. 2011, 58 (Suppl. S1), S104–S113. [Google Scholar] [CrossRef]
- Wagner, Z.; Montoy, J.C.C.; Drabo, E.F.; Dow, W.H. Incentives Versus Defaults: CostEffectiveness of Behavioral Approaches for HIV Screening. AIDS Behav. 2020, 24, 379386. [Google Scholar] [CrossRef] [PubMed]
- Zulliger, R.; Maulsby, C.; Solomon, L.; Baytop, C.; Orr, A.; Nasrullah, M.; Shouse, L.; DiNenno, E.; Holtgrave, D. Cost-utility of HIV Testing Programs Among Men Who Have Sex with Men in the United States. AIDS Behav. 2017, 21, 619625. [Google Scholar] [CrossRef] [PubMed]
- Hoenigl, M.; Chaillon, A.; Mehta, S.R.; Smith, D.M.; Graff-Zivin, J.; Little, S.J. Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions. J. Infect. 2016, 73, 476–484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hoenigl, M.; Graff-Zivin, J.; Little, S.J. Costs per Diagnosis of Acute HIV Infection in Community-based Screening Strategies: A Comparative Analysis of Four Screening Algorithms. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2016, 62, 501–511. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Long, E.F. HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: A cost-effectiveness analysis. PLoS ONE 2011, 6, e27625. [Google Scholar] [CrossRef]
- Juusola, J.L.; Brandeau, M.L.; Long, E.F.; Owens, D.K.; Bendavid, E. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. AIDS 2011, 25, 1779–1787. [Google Scholar] [CrossRef] [Green Version]
- Hutchinson, A.B.; Patel, P.; Sansom, S.L.; Farnham, P.G.; Sullivan, T.J.; Bennett, B.; Kerndt, P.R.; Bolan, R.K.; Heffelfinger, J.D.; Prabhu, V.S.; et al. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: A comparison of three public health settings. PLoS Med. 2010, 7, e1000342. [Google Scholar] [CrossRef]
- Neilan, A.M.; Bulteel, A.J.B.; Hosek, S.G.; A Foote, J.H.; A Freedberg, K.; Landovitz, R.J.; Walensky, R.P.; Resch, S.C.; Kazemian, P.; Paltiel, A.D.; et al. Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2020, 73, e1927–e1935. [Google Scholar] [CrossRef]
- DiNenno, E.A.; Prejean, J.; Delaney, K.P.; Bowles, K.; Martin, T.; Tailor, A.; Dumitru, G.; Mullins, M.M.; Hutchinson, A.; Lansky, A. Evaluating the Evidence for More Frequent Than Annual HIV Screening of Gay, Bisexual, and Other Men Who Have Sex With Men in the United States: Results From a Systematic Review and CDC Expert Consultation. Public Health Rep. 2018, 133, 3–21. [Google Scholar] [CrossRef]
- Qureshi, N.; Javanbakht, M.; Tadesse, M.; Malek, M.; Cox, G. Risk-Based HIV Testing at Los Angeles County Men’s Central Jail. J. Correct. Health Care Off. J. Natl. Comm. Correct. Health Care 2018, 24, 309–319. [Google Scholar] [CrossRef]
- Prabhu, V.S.; Farnham, P.G.; Hutchinson, A.B.; Soorapanth, S.; Heffelfinger, J.D.; Golden, M.R.; Brooks, J.T.; Rimland, D.; Sansom, S.L. Cost-Effectiveness of HIV Screening in STD Clinics, Emergency Departments, and Inpatient Units: A model-Based Analysis. PLoS ONE 2011, 6, e19936. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bert, F.; Gualano, M.R.; Biancone, P.; Brescia, V.; Camussi, E.; Martorana, M.; Thomas, R.; Secinaro, S.; Siliquini, R. HIV screening in pregnant women: A systematic review of cost-effectiveness studies. Int. J. Health Plan. Manag. 2018, 33, 31–50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ibekwe, E.; Haigh, C.; Duncan, F.; Fatoye, F. Economic impact of routine opt-out antenatal human immune deficiency virus screening: A systematic review. J. Clin. Nurs. 2017, 26, 3832–3842. [Google Scholar] [CrossRef] [PubMed]
- Cipriano, L.E.; Zaric, G.S.; Holodniy, M.; Bendavid, E.; Owens, D.K.; Brandeau, M.L. Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users. PLoS ONE 2012, 7, e45176. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Harawa, N.T.; Brewer, R.; Buckman, V.; Ramani, S.; Khanna, A.; Fujimoto, K.; Schneider, J.A. HIV, Sexually Transmitted Infection, and Substance Use Continuum of Care Interventions Among Criminal Justice-Involved Black Men Who Have Sex With Men: A Systematic Review. Am. J. Public Health 2018, 108, e1–e9. [Google Scholar] [CrossRef]
- Neilan, A.M.; Dunville, R.; Ocfemia, M.C.B.; Salomon, J.; Francke, J.A.; Bulteel, A.J.; Wang, L.Y.; Hsu, K.K.; DiNenno, E.A.; Walensky, R.P.; et al. The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV. J. Adolesc. Health Off. Publ. Soc. Adolesc. Med. 2018, 62, 22–28. [Google Scholar] [CrossRef] [Green Version]
- Sanders, G.D.; Bayoumi, A.M.; Holodniy, M.; Owens, D.K. Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann. Intern. Med. 2008, 148, 889–903. [Google Scholar] [CrossRef]
- Stevens, E.R.; Nucifora, K.A.; Zhou, Q.; Braithwaite, R.S.; Cleland, C.M.; Ritchie, A.S.; Kutnick, A.H.; Gwadz, M.V. Cost-Effectiveness of Peer- Versus Venue-Based Approaches for Detecting Undiagnosed HIV Among Heterosexuals in High-Risk New York City Neighborhoods. J. Acquir. Immune Defic. Syndr. 2018, 77, 183–192. [Google Scholar] [CrossRef]
- Dowdy, D.W.; Rodriguez, R.M.; Hare, C.B.; Kaplan, B. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department. Acad. Emerg. Med. 2011, 18, 745–753. [Google Scholar] [CrossRef]
- Schackman, B.R.; Metsch, L.R.; Colfax, G.N.; Leff, J.A.; Wong, A.; Scott, C.A.; Feaster, D.J.; Gooden, L.; Matheson, T.; Haynes, L.F.; et al. The cost-effectiveness of rapid HIV testing in substance abuse treatment: Results of a randomized trial. Drug Alcohol Depend. 2013, 128, 90–97. [Google Scholar] [CrossRef]
- Nussbaum, E.S.; Kallmes, K.; Lowary, J.; Nussbaum, L.A. Routine screening for hepatitis C viral infection in patients undergoing elective cranial neurosurgery. J. Neurosurg. 2018, 131, 941–948. [Google Scholar] [CrossRef] [Green Version]
- Scott, R.K.; Crochet, S.; Huang, C.-C. Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis. Infect. Dis. Obstet. Gynecol. 2018, 2018, 6024698. [Google Scholar] [CrossRef] [Green Version]
- Winkelmann, M.; Sorrentino, J.N.; Klein, M.; Macke, C.; Mommsen, P.; Brand, S.; Schroter, C.; Krettek, C.; Zeckey, C. Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty? Orthop. Traumatol. Surg. Res. OTSR 2016, 102, 513–516. [Google Scholar] [CrossRef]
- Jacobsen, M.M.; Walensky, R.P. Modeling and Cost-Effectiveness in HIV Prevention. Curr. HIV/AIDS Rep. 2016, 13, 64–75. [Google Scholar] [CrossRef] [Green Version]
- Shah, M.; Risher, K.; Berry, S.A.; Dowdy, D.W. The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2016, 62, 220–229. [Google Scholar] [CrossRef] [Green Version]
- Lucas, A.; Armbruster, B. The cost-effectiveness of expanded HIV screening in the United States. AIDS 2013, 27, 795–801. [Google Scholar] [CrossRef]
- Thornton, A.C.; Delpech, V.; Kall, M.M.; Nardone, A. HIV testing in community settings in resource-rich countries: A systematic review of the evidence. HIV Med. 2012, 13, 416–426. [Google Scholar] [CrossRef]
- Stevinson, K.; Martin, E.G.; Marcella, S.; Paul, S.M. Cost effectiveness analysis of the New Jersey rapid testing algorithm for HIV testing in publicly funded testing sites. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 2011, 52 (Suppl. S1), S29–S33. [Google Scholar] [CrossRef]
- Long, E.F.; Brandeau, M.L.; Owens, D.K. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann. Intern. Med. 2010, 153, 778–789. [Google Scholar] [CrossRef] [Green Version]
- Paltiel, A.D.; Walensky, R.P.; Schackman, B.R.; Seage, G.R.; Mercincavage, L.M.; Weinstein, M.C.; Freedberg, K.A. Expanded HIV screening in the United States: Effect on clinical outcomes, HIV transmission, and costs. Ann. Intern. Med. 2006, 145, 797–806. [Google Scholar] [CrossRef]
- Anonymous. Summaries for patients. Expanded HIV screening in the United States: Effect on clinical outcomes, HIV transmission, and costs. Ann. Intern. Med. 2006, 145, I30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saraniti, B.A. Optimal pooled testing. Health Care Manag. Sci. 2006, 9, 143–149. [Google Scholar] [CrossRef] [PubMed]
- Komorowski, M.; Raffa, J. Markov Models and Cost Effectiveness Analysis: Applications in Medical Research. In Secondary Analysis of Electronic Health Records; Springer: Cham, Switzerland, 2016; pp. 351–367. [Google Scholar]
- Shrestha, R.K.; Chavez, P.R.; Noble, M.; Sansom, S.L.; Sullivan, P.S.; Mermin, J.H.; MacGowan, R.J. Estimating the costs and cost-effectiveness of HIV self-testing among men who have sex with men, United States. J. Int. AIDS Soc. 2020, 23, e25445. [Google Scholar] [CrossRef] [PubMed]
- LaPointe, J. Value-Based Care News: 36% of Payments Tied to Alternative Payment Models in 2018. Available online: https://revcycleintelligence.com/news/36-of-payments-tied-toalternative-payment-models-in-2018 (accessed on 28 January 2021).
- Institute of Medicine (U.S.) Committee on HIV Screening and Access to Care. HIV Screening and Access to Care: Exploring Barriers and Facilitators to Expanded HIV Testing; National Academies Press (U.S.): Washington, DC, USA, 2021. [Google Scholar]
- Flash, C.A.; Pasalar, S.; Hemmige, V.; Davila, J.A.; Hallmark, C.J.; McNeese, M.; Miertschin, N.; Ruggerio, M.C.; Giordano, T.P. Benefits of a routine opt-out HIV testing and linkage to care program for previously diagnosed patients in publicly funded emergency departments in Houston, TX. J. Acquir. Immune. Defic. Syndr. 2015, 69 (Suppl. S1), S8–S15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Haukoos, J.S.; Hopkins, E.; Bender, B.; Al-Tayyib, A.; Long, J.; Harvey, J.; Irby, J.; Bakes, K.; Denver Emergency Department HIV Testing Research Consortium; Al-Tayyib, A. Use of kiosks and patient understanding of optout and opt-in consent for routine rapid human immunodeficiency virus screening in the emergency department. Acad. Emerg. Med. 2012, 19, 287–293. [Google Scholar] [CrossRef]
- Haukoos, J.S.; Hopkins, E.; Byyny, R.L.; Conroy, A.A.; Silverman, M.; Eisert, S.; Thrun, M.; Wilson, M.; Boyett, B.; Heffelfinger, J.D.; et al. Design and implementation of a controlled clinical trial to evaluate the effectiveness and efficiency of routine opt-out rapid human immunodeficiency virus screening in the emergency department. Acad. Emerg. Med. 2009, 16, 800–808. [Google Scholar] [CrossRef]
- Haukoos, J.S.; Hopkins, E.; Conroy, A.A.; Silverman, M.; Byyny, R.L.; Eisert, S.; Thrun, M.W.; Wilson, M.L.; Hutchinson, A.B.; Forsyth, J.; et al. Routine opt-out rapid HIV screening and detection of HIV infection in emergency department patients. JAMA 2010, 304, 284–292. [Google Scholar] [CrossRef] [Green Version]
- Hoxhaj, S.; Davila, J.A.; Modi, P.; Kachalia, N.; Malone, K.; Ruggerio, M.C.; Miertschin, N.; Brock, P.; Fisher, A.; Mitts, B. Using nonrapid HIV technology for routine, opt-out HIV screening in a high-volume urban emergency department. Ann. Emerg. Med. 2011, 58 (Suppl. S1), S79–S84. [Google Scholar] [CrossRef]
- Leidel, S.; McConigley, R.; Boldy, D.; Wilson, S.; Girdler, S. Australian health care providers’ views on opt-out HIV testing. BMC Public Health 2015, 15, 888. [Google Scholar] [CrossRef] [Green Version]
- Montoy, J.C.; Dow, W.H.; Kaplan, B.C. Patient choice in opt-in, active choice, and opt-out HIV screening: Randomized clinical trial. BMJ Clin. Res. Ed. 2016, 532, h6895. [Google Scholar] [CrossRef]
- Osorio, G.; Hoenigl, M.; Quartarolo, J.; Barger, K.; Morris, S.R.; Reed, S.L.; Lee, J.; Little, S.J. Evaluation of opt-out inpatient HIV screening at an urban teaching hospital. AIDS Care 2017, 29, 1014–1018. [Google Scholar] [CrossRef] [Green Version]
- White, D.A.; Scribner, A.N.; Martin, M.E.; Tsai, S. A Comparison of Patient Satisfaction with Emergency Department Opt-In and Opt-Out Rapid HIV Screening. AIDS Res. Treat. 2012, 2012, 904916. [Google Scholar] [CrossRef] [Green Version]
- Anaya, H.D.; Hoang, T.; Golden, J.F.; Goetz, M.; Gifford, A.L.; Bowman, C.; Osborn, T.; Owens, D.K.; Sanders, G.D.; Asch, S.M. Improving HIV screening and receipt of results by nurse-initiated streamlined counseling and rapid testing. J. Gen. Intern. Med. 2008, 23, 800–807. [Google Scholar] [CrossRef] [Green Version]
- Montoy, J.C.C.; Dow, W.H.; Kaplan, B.C. Cash incentives versus defaults for HIV testing: A randomized clinical trial. PLoS ONE 2018, 6, e0199833. Available online: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199833 (accessed on 28 January 2021).
- Suarez-Durall, P.; Osborne, M.S.; Enciso, R.; Melrose, M.D.; Mulligan, R. Results of offering oral rapid HIV screening within a dental school clinic. Special care in dentistry: Official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry. Spec. Care Dentist. 2019, 39, 188–200. [Google Scholar] [CrossRef]
- Funding: Federal HIV Budget. 2020. Available online: https://www.hiv.gov/federal-response/funding/budget (accessed on 15 October 2022).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Serag, H.; Clark, I.; Naig, C.; Lakey, D.; Tiruneh, Y.M. Financing Benefits and Barriers to Routine HIV Screening in Clinical Settings in the United States: A Scoping Review. Int. J. Environ. Res. Public Health 2023, 20, 457. https://doi.org/10.3390/ijerph20010457
Serag H, Clark I, Naig C, Lakey D, Tiruneh YM. Financing Benefits and Barriers to Routine HIV Screening in Clinical Settings in the United States: A Scoping Review. International Journal of Environmental Research and Public Health. 2023; 20(1):457. https://doi.org/10.3390/ijerph20010457
Chicago/Turabian StyleSerag, Hani, Isabel Clark, Cherith Naig, David Lakey, and Yordanos M. Tiruneh. 2023. "Financing Benefits and Barriers to Routine HIV Screening in Clinical Settings in the United States: A Scoping Review" International Journal of Environmental Research and Public Health 20, no. 1: 457. https://doi.org/10.3390/ijerph20010457